Michael Carlotta

Title: Michael Carlotta: Innovator in Nucleic Acid Detection

Introduction

Michael Carlotta is an accomplished inventor based in Lilburn, Georgia. He has made significant contributions to the field of biotechnology, particularly in the detection of nucleic acids in biological samples. His innovative work has the potential to enhance diagnostic processes in various medical applications.

Latest Patents

Michael Carlotta holds a patent for a device and method for detecting nucleic acids in biological samples. This device features a sample port for receiving a biological sample, a solid-state membrane, a sample conduit, a lysis station, a wash station, an elution station, a waste chamber, and a reaction chamber. The design allows for the mixing of a sample and lysis agent to form a sample-lysis mixture, which is then processed to capture and purify nucleic acids. The captured nucleic acids are subsequently amplified and detected, showcasing a significant advancement in the field.

Career Highlights

Carlotta's career is marked by his role at Definitive Biotechnologies LLC, where he has been instrumental in developing innovative solutions for biological detection. His expertise in biotechnology has positioned him as a key player in the industry, contributing to advancements that could improve diagnostic accuracy and efficiency.

Collaborations

Throughout his career, Michael has collaborated with notable colleagues, including Timothy Alcorn and Steven Dietl. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Michael Carlotta's contributions to the field of biotechnology, particularly through his patent for nucleic acid detection, highlight his role as an innovator. His work at Definitive Biotechnologies LLC and collaborations with fellow professionals underscore the importance of teamwork in driving advancements in medical technology.